Status:
UNKNOWN
Correlation of Lung Ultrasonography With Chest CT Findings in Cancer Patients With COVID-19 Viral Pneumonia
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Cancer Patients
Eligibility:
All Genders
16-60 years
Brief Summary
Thoracic imaging, either with chest X-ray (CXR) or computed tomography (CT), is an essential part of the diagnosis of coronavirus disease-19 (COVID-19) in patients admitted to hospital with fever or r...
Eligibility Criteria
Inclusion
- The study population will include cancer patients admitted to South Egypt Cancer Institute (SECI), Asyut University, Egypt with COVID-19 viral pneumonia in the period from March 2022 to December 2023, with ages ranging from 18 to 60 years old, of male or female gender, and CT Chest findings of CORAD 4, 5 and 6 with moderate and severe symptoms.
- All cancer patients are diagnosed COVID-19 by PCR from a nasopharyngeal swab.
Exclusion
- Critical conditions need for ICU at the time of admission, presence of severe cardiorespiratory illness other than COVID-19 viral pneumonia, hepatic and renal diseases, coagulopathy, and patient refusal to share in our study will be considered as exclusion criteria.
Key Trial Info
Start Date :
March 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05279378
Start Date
March 30 2022
End Date
February 28 2025
Last Update
April 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt cancei institute
Asyut, Egypt